Discounted Cash Flow (DCF) Analysis Levered
Health Discovery Corporation (HDVY)
$0.0003
0.00 (0.00%)
All numbers are in Millions, Currency in USD
Free Cash Flow
Year A/P | 2016 Actual | 2017 Actual | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Projected | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected |
Revenue | 0.04 | 0.04 | 0.04 | 1.52 | 0 | 0.01 | 0.08 | 0.75 | 6.79 | 61.58 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue (%) | ||||||||||
Operating Cash Flow | -0.47 | -0.31 | -0.28 | 2.20 | -1.38 | -2.54 | -23.09 | -209.55 | -1,901.87 | -17,261.27 |
Operating Cash Flow (%) | ||||||||||
Capital Expenditure | - | - | - | - | - | - | - | - | - | - |
Capital Expenditure (%) | ||||||||||
Free Cash Flow | - | - | - | - | - | -2.54 | -23.09 | -209.55 | -1,901.87 | -17,261.27 |
Weighted Average Cost Of Capital
Share price | $ 0.0,003 |
---|---|
Beta | 1.853 |
Diluted Shares Outstanding | 397.63 |
Cost of Debt | |
Tax Rate | 0.00 |
After-tax Cost of Debt | 4.72% |
Risk-Free Rate | |
Market Risk Premium | |
Cost of Equity | 12.310 |
Total Debt | 0.21 |
Total Equity | 0.12 |
Total Capital | 0.33 |
Debt Weighting | 63.99 |
Equity Weighting | 36.01 |
Wacc |
Build Up Free Cash Flow
Year A/P | 2016 Actual | 2017 Actual | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Projected | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected |
Revenue | 0.04 | 0.04 | 0.04 | 1.52 | 0 | 0.01 | 0.08 | 0.75 | 6.79 | 61.58 |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | -0.47 | -0.31 | -0.28 | 2.20 | -1.38 | -2.54 | -23.09 | -209.55 | -1,901.87 | -17,261.27 |
Capital Expenditure | - | - | - | - | - | - | - | - | - | - |
Free Cash Flow | - | - | - | - | - | -2.54 | -23.09 | -209.55 | -1,901.87 | -17,261.27 |
WACC | ||||||||||
PV LFCF | -2.37 | -20 | -168.92 | -1,426.77 | -12,051.49 | |||||
SUM PV LFCF | -13,669.54 |
Terminal Value
Growth in perpetuity method: | |
---|---|
Long-term growth rate | |
WACC (%) | 7.45 |
Free cash flow (t + 1) | -17,606.49 |
Terminal Value | -323,054.94 |
Present Value of Terminal Value | -225,550.76 |
Intrinsic Value
Enterprise Value | -239,220.30 |
---|---|
Net Debt | -0.70 |
Equity Value | -239,219.59 |
Shares Outstanding | 397.63 |
Equity Value Per Share | -601.61 |